MyChart

Log in to our secure, personalized website to manage your care (formerly myMDAnderson).
Request an Appointment

If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.
Appointment Information

New Patients Current Patients Referring Physicians
Donate Today

Locations
Contact Us
Our Doctors
- Spanish
- Arabic
- Chinese
- Turkish

Clear

close

Clear

MyChart

Donate Today

Locations
Contact Us
- Spanish
- Arabic
- Chinese
- Turkish

Request an Appointment
New Patients
Current Patients
Referring Physicians

Patients & Family
Prevention & Screening
Donors & Volunteers
For Physicians
Research
Education & Training
Cancer Moonshots

Other Ways to Help

Attend Events

Sprint for Life

Top

Jump To:

Back

Sprint for Life

Sprint for Life

Thank you to everyone who participated in the 21st annual Sprint for Life® 5K Run/Walk. It was a great success. Sprint for Life 2019 will take place on Saturday, May 4.

Hosted by the Gynecologic Oncology and Reproductive Medicine department since 1998, Sprint for Life has now raised over $5.2 million for the Blanton-Davis Ovarian Cancer Research Program at MD Anderson. Laura Lee Scurlock Blanton and Sandra G. Davis are the courageous women for whom the Blanton-Davis Ovarian Cancer Research Program is named.

2018 Sprint for Life Leadership

Sprint for Life appreciates the support of Event Chair Kim Podraza and of Honorary Co-Chairs Kelli Blanton, Eddy Scurlock Blanton Sr., Lee Davis, Gayle Goodman, Wendy Schmitz and Kimberly Sperling.

On Race Day, survivors, their families and friends, businesses and MD Anderson employees came together to achieve two goals:

Raise funds for research
Increase awareness about ovarian cancer and its symptoms

Why support is important

This year, about 22,440 women will be diagnosed with ovarian cancer and about 14,070 women will die, making ovarian cancer the leading cause of death from gynecologic cancers.

Unfortunately, because there is no screening or early detection test available and ovarian cancer symptoms are subtle, only 25% of ovarian tumors are detected before they have progressed to an advanced stage.